May 2026

Scrapped CGM sensors stolen, sold to patients—Dexcom pledges to hold thieves accountable ()
FDA shares another warning about Impella heart pumps after death ()
FDA sees potential in new AI software for monitoring heart failure patients ()
SAPT after TAVR linked to key benefits over DAPT, new data confirm ()
FDA gives greenlight to new AI tool for managing heart failure patients ()
American Heart Association takes on cardiac amyloidosis with new initiative ()
Have clinicians been wrong about how they diagnose PAD? ()
Prasugrel after PCI outperforms other common antiplatelet drugs ()
AI tool helps remote monitoring clinics explore patient data ()
Insulet recalls 7M insulin delivery pods due to safety risk ()
Diabetes drugs improve survival for patients with ‘broken hearts’ ()
Cardiology groups celebrate bill that could improve Medicare payments ()
Conduction system pacing after TAVR linked to improved outcomes in new meta-analysis ()
Tech breakthroughs, new policies help cardiologists perform more concomitant EP procedures ()
J&J recalls certain heart pump controllers due to hardware issues ()
FDA confirms Class I recall for vascular device used by cardiologists and surgeons ()
BATMAN to the rescue: TMVR technique helps cardiologists reduce risk of LVOT obstruction ()
Inflammation may help explain how GLP-1 drugs prevent AFib ()
How TAVR valve implant depth impacts clinical outcomes ()
FDA warns public about Johnson & Johnson heart pump controllers after patient death ()
Advocacy group wants TAVR changes, urging Trump admin to ‘stop getting in between patients and their doctors’ ()
Medtronic recalls thousands of surgical devices due to contamination risk ()
'Compelling' study shows promise of new pulmonary embolectomy system ()
Artivion acquires medtech company behind FDA-approved endovascular device for $135M ()
Shockwave Medical's new IVL catheter overcomes previous limitations ()
SMART update: Self-expanding TAVR valves still linked to superior durability after 3 years ()
Exploring the latest data in PFA and leadless conduction system pacing ()
More good news for Boston Scientific’s coronary IVL tech ()
FDA approves first-in-class hypertension drug from AstraZeneca ()
Cardiologists scramble to prepare for mandatory heart failure payment model ()
Boston Scientific invests $1.5B in MiRus with option to buy its TAVR business ()
FDA clears next-gen contrast management system for the cath lab ()
Heartflow reports significant revenue growth as CCTA sees wider adoption ()
Trump administration exempts doctors from work visa freeze ()
Thousands of reprocessed EP catheters recalled ()
PFA has been a game-changer for heart patients—but there are still risks ()
Compensation in cardiology now outpacing all other healthcare specialties ()
Blood pressure drug recalled after failed test ()
Cardiac amyloidosis in the spotlight at Heart Failure 2026 ()
Cardiologists are first in world to use new leaflet-splitting technique during TAVR ()
AI uses 12-lead ECGs to predict long-term stroke risk ()
J&J launches Shockwave Medical’s next-generation coronary IVL catheter ()
Routine testing is needed to locate patients who may not benefit from clopidogrel ()
Key points to remember when performing cardiac ablations in ASCs ()
Cardiologist finds possible link between sexual dreams and heart disease ()
Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipients ()
Is TAVR too common among younger patients? New data prompt a ‘call to action’ ()
First-of-its-kind drainage device helps limit heart failure rehospitalizations ()
SCAI seeks female interventional cardiologists for radiation risk study ()
FDA clears high-pressure balloon catheter for BAV procedures ()
New coronary IVL tech from Boston Scientific impresses in first-in-human study ()
ASNC speaks to policymakers about prior authorization, Medicare cuts and more ()
Harold Litt named new editor of RSNA's cardiothoracic imaging journal ()
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia ()
FDA announces more recalls due to risk of syringe breaking during treatment ()
How expert guidelines have influenced TAVR vs. SAVR decisions ()
Upfront costs of robotic heart surgery are high—but it may be a smart investment ()
Physician and his practice to pay $6.7M for allegedly performing unnecessary vascular procedures ()
PHOTO GALLERY: Cardiac surgery technologies at the AATS 106th Annual Meeting ()
Heart experts concerned after Trump administration authorizes fruit-flavored e-cigarettes ()
Cannabis use increases risk of death, heart attack for ED patients ()
Resilia tissue developed by Edwards Lifesciences associated with long-term durability ()
CCTA brings clarity, better outcomes to CTO PCI ()
Physicians chime in: Coronary plaque staging offers more precise cardiac patient management ()
SCCT President: Key trends in cardiac CT ()
Impella 5.5 shows promise in certain non-shock, high-risk cardiac surgery patients ()
First patient enrolled in massive heart failure trial ()
TAVR or SAVR? Cardiologists and heart surgeons highlight the care that goes into each decision ()
FDA details Class I catheter recall over safety risk ()
Advanced AI helps 3D imaging labs evolve with the times ()
New ways to predict TAVR outcomes for individual heart patients ()
Stroke prevention devices for TAVR fail to make an impact ()
Surgery still outperforms GLP-1 drugs in terms of heart health ()
Redo TAVR: Supra-annular, intra-annular valves linked to comparable outcomes ()